Drug Trial Radar · NCT00586625
Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers
Last checked: Nov 20, 2026Latest source record: Feb 15, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
861
Actual
Start
Oct 2007
Primary completion
May 2008
Sponsor
- Lead sponsor
- Bausch & Lomb IncorporatedIndustry
- Sponsor type
- Industry
- First posted
- Jan 4, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 3 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Safety study for bepotastine besilate ophthalmic solution in normal volunteers
Conditions
- Allergic Conjunctivitis
Interventions
BepreveDrug
One drop, both eyes, twice a day
PlaceboDrug
One drop, both eyes, twice a day
Primary outcomes
What the sponsor says the trial is designed to measure.
- Ocular ComfortTime frame: Day 8 & Day 22
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.